HCW9218 for Advanced Pancreatic Cancer

Clinical trial NCT05304936 · COMPLETED

Trial details

NCT number: NCT05304936
Sponsor: ImmunityBio, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Carcinoma

Start date: 2022-10-17
Primary completion: 2025-02-15
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.